# Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT)

> **NCT00683696** · PHASE2,PHASE3 · TERMINATED · sponsor: **Biotronik, Inc.** · enrollment: 1680 (actual)

## Conditions studied

- Heart Failure
- Ventricular Dyssynchrony

## Interventions

- **DEVICE:** Implantable Cardioverter Defibrillator with Cardiac Resynchronization Therapy (BIOTRONIK Lumax HF-T CRT-D)

## Key facts

- **NCT ID:** NCT00683696
- **Lead sponsor:** Biotronik, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-08
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 1680 (ACTUAL)
- **Last updated:** 2018-01-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00683696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00683696, "Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT)". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT00683696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*